Company Profile
Navidea Stock Price, News & Analysis
- Ticker:
- NAVB
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for NAVB.
Company overview
Business overview
Navidea Biopharmaceuticals is a biotechnology company that has historically focused on diagnostic and targeted molecular imaging approaches. Its story reflects the difficulty of sustaining a narrow clinical and commercial platform over time.
Geographic Base and Sector Classification
Navidea is headquartered in the United States and listed on NYSE American. It sits in small-cap biotech and medical imaging-adjacent therapeutics.
Business Model Characteristics
The company depends on corporate restructuring, financing, and the ability to preserve value in a very narrow asset set. Investors historically watched regulatory developments and strategic shifts.
Position Within the Biotechnology Landscape
Navidea occupies a legacy small-cap biotech niche. The stock has long been driven more by capital structure and survival than by broad commercial scale.
Future catalysts
Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on what remains.
Recent news
- 01
Navidea Biopharmaceuticals, Inc. Files for Bankruptcy
Source: Navidea
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Navidea do?
Navidea Biopharmaceuticals is a biotechnology company that has historically focused on diagnostic and targeted molecular imaging approaches. Its story reflects the difficulty of sustaining a narrow clinical and commercial platform over time.
On which exchange is NAVB stock listed?
Navidea (NAVB) is associated with AMEX, United States, Biopharma.
What is Navidea?
Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone.
Which conditions is Navidea targeting with Navidea?
Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone.
How does Navidea describe recent progress with Navidea?
Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone.
What is Biopharmaceuticals?
Navidea Biopharmaceuticals is a biotechnology company that has historically focused on diagnostic and targeted molecular imaging approaches.
What should investors watch for with Biopharmaceuticals?
Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on what remains.
What future catalysts are investors watching for Navidea?
Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on what remains.